Search
for

    Glossary Mucositis

    painful inflammation of mucous membranes, often from cancer treatments

    Mucositis is a painful inflammation and ulceration of the mucous membranes lining the digestive tract, often occurring as a side effect of chemotherapy and radiation therapy. It can lead to symptoms such as mouth sores, difficulty swallowing, and increased risk of infection, significantly impacting a patient's quality of life and ability to continue cancer treatment.

    Related Terms

    Research 10 of 485

    1. Comprehensive Case Analysis: Diagnosing and Managing Myositis in Newly Diagnosed Systemic Lupus Erythematosus Patients in Indonesia SHILAP Revista de lepidopterología · 2026
    2. Comprehensive Case Analysis: Diagnosing and Managing Myositis in Newly Diagnosed Systemic Lupus Erythematosus Patients in Indonesia. PubMed · 2026
    3. 062 A case of autoimmune facial swelling, weakness and sensorineuropathy with lower limb myositis Journal of Neurology Neurosurgery & Psychiatry · 2022
    4. Preclinical efficacy and safety evaluation of a topical mesenchymal stem cell derived conditioned media gel for oral mucositis management Scientific Reports · 2026
    5. Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study Medical Science Monitor · 2017 · 38 citations
    6. Comparison of the therapeutic effects of the dietary and topical forms of Zizyphus jujuba extract on oral mucositis induced by 5-fluorouracil: A golden hamster model Journal of Clinical and Experimental Dentistry · 2015 · 37 citations
    7. Decade Long Survey of Low-level Laser Therapy/Photobiomodulation (LLLT/PBM) Therapy for Oral Mucositis Treatment Medical Lasers · 2021 · 4 citations
    8. Multifunctional Hydrogel with Dual Functions of ROS Scavenging and Responsive Antibiotic Release for Synergistic Oral Mucositis Treatment ACS Omega · 2026
    9. A 39‐year‐old woman with Lupus, Myositis, and a Recalcitrant Vasculopathy Arthritis Care & Research · 2010 · 6 citations
    10. Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer Annals of oncology · 2004 · 1461 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →